Literature DB >> 8067410

Heart failure due to chronic experimental aortic regurgitation.

N M Magid1, G Opio, D C Wallerson, M S Young, J S Borer.   

Abstract

Previously reported experimental models of aortic regurgitation generally have manifested normal systolic performance and have not developed heart failure [Magid et al. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H226-H233, 1992]. To determine whether more severe chronic experimental aortic regurgitation would generate systolic malperformance, heart failure, and emulate the human disease process, 11 New Zealand White rabbits underwent surgical induction of aortic regurgitation and 5 control animals underwent sham operation. Doppler echocardiography was performed serially for up to 3 yr, and pathological studies were performed at necropsy. Left ventricular internal dimension at end diastole increased 80% (P < 0.00002) and left ventricular weight increased 250% (P < 0.0002) in aortic regurgitant rabbits (regurgitant fraction 52 +/- 13%) compared with baseline values. Six of 11 aortic regurgitant animals died with pathological evidence of congestive heart failure at 1.5 +/- 0.8 yr postoperatively; 2 of these developed severe systolic malperformance, manifest as fractional shortenings of 15 and 19% at 1.6 and 1.7 yr, respectively. Five of 11 aortic regurgitant animals survived until killed at 2.9 +/- 0.1 yr. Thus moderate-to-severe chronic aortic regurgitation in rabbits frequently results in heart failure and systolic dysfunction and may usefully model chronic aortic regurgitation and heart failure in humans.

Entities:  

Mesh:

Year:  1994        PMID: 8067410     DOI: 10.1152/ajpheart.1994.267.2.H556

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Experimental evaluation of radiotracers: role of intact biological models.

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

2.  Antimyosin antibody imaging in experimental aortic regurgitation.

Authors:  P Lu; P Zanzonico; S M Goldfine; R Hardoff; N Magid; R Gentile; E M Herrold; J S Borer
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

3.  The hemodynamic effects of acute aortic regurgitation into a stiffened left ventricle resulting from chronic aortic stenosis.

Authors:  Ikechukwu Okafor; Vrishank Raghav; Prem Midha; Gautam Kumar; Ajit Yoganathan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-04-22       Impact factor: 4.733

4.  Hypertrophy signaling pathways in experimental chronic aortic regurgitation.

Authors:  Niels Thue Olsen; Veronica L Dimaano; Thomas Fritz-Hansen; Peter Sogaard; Khalid Chakir; Kristian Eskesen; Charles Steenbergen; David A Kass; Theodore P Abraham
Journal:  J Cardiovasc Transl Res       Date:  2013-07-26       Impact factor: 4.132

Review 5.  Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.

Authors:  E Dale Abel; Torsten Doenst
Journal:  Cardiovasc Res       Date:  2011-01-21       Impact factor: 10.787

6.  The myosin activator omecamtiv mecarbil improves wall stress in a rat model of chronic aortic regurgitation.

Authors:  Bachar El Oumeiri; Philippe van de Borne; Géraldine Hubesch; Antoine Herpain; Filippo Annoni; Pascale Jespers; Constantin Stefanidis; Kathleen Mc Entee; Frédéric Vanden Eynden
Journal:  Physiol Rep       Date:  2021-08

7.  Outflow tract cushions perform a critical valve-like function in the early embryonic heart requiring BMPRIA-mediated signaling in cardiac neural crest.

Authors:  Aya Nomura-Kitabayashi; Colin K L Phoon; Satoshi Kishigami; Julie Rosenthal; Yasutaka Yamauchi; Kuniya Abe; Ken-ichi Yamamura; Rajeev Samtani; Cecilia W Lo; Yuji Mishina
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

8.  Congestive heart failure: experimental model.

Authors:  Antonio Francesco Corno; Xue Cai; Caroline B Jones; Giuseppina Mondani; Mark R Boyett; Jonathan Charles Jarvis; George Hart
Journal:  Front Pediatr       Date:  2013-10-28       Impact factor: 3.418

9.  Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats.

Authors:  Bachar El-Oumeiri; Kathleen Mc Entee; Filippo Annoni; Antoine Herpain; Frédéric Vanden Eynden; Pascal Jespers; Guido Van Nooten; Philippe van de Borne
Journal:  BMC Cardiovasc Disord       Date:  2018-05-21       Impact factor: 2.298

Review 10.  Rabbit models of heart disease.

Authors:  Steven M Pogwizd; Donald M Bers
Journal:  Drug Discov Today Dis Models       Date:  2009-03-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.